Peer review reports
From: A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP)
Original Submission | ||
---|---|---|
21 Aug 2019 | Submitted | Original manuscript |
9 Dec 2019 | Reviewed | Reviewer Report - Sandeep Gupta |
3 Jan 2020 | Reviewed | Reviewer Report - Mark Wielpütz |
29 Jan 2020 | Author responded | Author comments - Jonathan Fallowfield |
2 Feb 2020 | Reviewed | Reviewer Report - Sandeep Gupta |
3 Feb 2020 | Reviewed | Reviewer Report - Mark Wielpütz |
18 Feb 2020 | Reviewed | Reviewer Report - Riaz Qureshi |
20 Feb 2020 | Author responded | Author comments - Jonathan Fallowfield |
Resubmission - Version 2 | ||
29 Jan 2020 | Submitted | Manuscript version 2 |
22 Feb 2020 | Reviewed | Reviewer Report - Riaz Qureshi |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
Publishing | ||
24 Feb 2020 | Editorially accepted | |
12 Mar 2020 | Article published | 10.1186/s13063-020-4203-9 |